Brink Biologics
  • Home
  • 404
  • Legal Notice
  • Management
  • NK-92 ® CELLS
  • PATENTS
  • Privacy Policy
  • Press Release
Select Page

Brink Biologics Announces License Agreement with Global Healthcare Company Fresenius Kabi SwissBioSim GmbH

by Jen Hodson | Sep 10, 2020 | Press Release

SAN DIEGO, Calif., September 10, 2020 – Brink Biologics, Inc. (“Brink”), a NantKwest, Inc. (NASDAQ: NK) affiliate and exclusively-licensed distributor of NantKwest’s proprietary off-the-shelf NK-92® natural killer cells in certain fields, announces the licensing of...

Categories

  • Press Release

Archives